Loading clinical trials...
Loading clinical trials...
This clinical trial evaluates the feasibility of performing oxygen-enhanced magnetic resonance imaging (MRI) to generate hypoxia maps in patients with intracranial tumors. Decreased levels of oxygen (...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
OHSU Knight Cancer Institute
Collaborators
NCT04278118 · Grade I Meningioma, Grade II Meningioma, and more
NCT03076255 · Brain and Nervous System, Intracranial Neoplasm, and more
NCT04462419 · Metastatic Intracranial Malignant Neoplasm, Recurrent Intracranial Neoplasm
NCT03539731 · Healthy Subject, Intracranial Neoplasm, and more
NCT05145049 · Intracranial Neoplasm, Hyperlactatemia, and more
OHSU Knight Cancer Institute
Portland, Oregon
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions